Tomas Walhelm

Publications

2025

Tomas Walhelm, Ioannis Parodis, Charlotta Enerbäck, Elizabeth Arkema, Christopher Sjöwall (2025) Comorbid psoriasis in systemic lupus erythematosus: a cohort study from a tertiary referral centre and the National Patient Register in Sweden Lupus Science and Medicine, Vol. 12, Article e001504 (Article in journal) https://dx.doi.org/10.1136/lupus-2025-001504

Alvaro Gomez, Tomas Walhelm, Floris C. Loeff, Andreas Jonsen, Dionysis Nikolopoulos, Bryan van den Broek, Anders A. Bengtsson, Annick de Vries, Theo Rispens, Christopher Sjöwall, Ioannis Parodis (2025) Belimumab concentrations and immunogenicity in relation to drug effectiveness and safety in SLE within a Swedish real-world setting Rheumatology, Vol. 64, p. 3797-3805 (Article in journal) https://dx.doi.org/10.1093/rheumatology/keaf128

2024

Floris C. Loeff, Ioannis Parodis, Tomas Walhelm, Andreas Jonsen, Dionysis Nikolopoulos, Christopher Sjöwall, Anders A. Bengtsson, Dorien Kos, Astrid van Leeuwen, Bryan van den Broek, Lisanne Dijk, Jorn Jeremiasse, Birgit S. Blomjous, Alexandre E. Voskuyl, Gerrit Jan Wolbink, Irene E. M. Bultin, Theo Rispens (2024) Belimumab concentration measurements using a homologous anti-idiotype immunoassay JIM - Journal of Immunological Methods, Vol. 532, Article 113717 (Article in journal) https://dx.doi.org/10.1016/j.jim.2024.113717

Tomas Walhelm, Lina Wirestam, Yvonne Enman, Ioannis Parodis, Christopher Sjöwall (2024) Factors Associated with Survival and Discontinuation of Anti-Malarial Agents in Systemic Lupus Erythematosus: Results from a Tertiary Swedish Referral Centre Journal of Clinical Medicine, Vol. 13, Article 1485 (Article in journal) https://dx.doi.org/10.3390/jcm13051485